New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
AstraZeneca PLC (AZN) vs Sanofi (SNY)
- AstraZeneca PLC AZN 175.62 +0.10%
- Sanofi SNY 46.58 +1.13%
AstraZeneca PLC and Sanofi are both Drug Manufacturers General companies. AstraZeneca PLC is the larger, with a market value of $272.1B against $111.3B — 2.4× the size. Sanofi trades at the lower P/E: 22.8× against 24.6×. Sanofi grew revenue faster over the last twelve months: 26.3% against 7.32%. AstraZeneca PLC has the higher net margin (17.7% vs 8.27%) and the higher return on invested capital (12.3% vs 7.05%). Both pay a dividend; Sanofi yields more (5.25% vs 1.83%). Across the 23 metrics below, Sanofi leads on 15 and AstraZeneca PLC on 8.
Valuation
Profitability
| Metric | AZN | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 81.94% | 73.44% | 73.01% |
| Operating margin | 23.68% | 18.73% | 18.34% |
| Net margin | 17.68% | 8.27% | 7.31% |
| Free cash flow margin | 10.15% | 40.26% | 18.56% |
| Return on equity | 22.56% | 0.00% | 20.02% |
| Return on assets | 9.41% | 3.24% | 2.28% |
| Return on invested capital | 12.31% | 7.05% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack